Qitan Tech

Executive Summary

Qitan Technology is a Chinese medtech company specializing in intelligent medical devices and diagnostic solutions, with a focus on respiratory care and chronic disease management. Founded in 2010 and based in Suzhou, the company leverages artificial intelligence and the Internet of Things to develop connected health products, including smart wearables and diagnostic tools. Positioned in the commercial stage with 50–200 employees, Qitan Tech targets the growing demand for remote patient monitoring and chronic disease management in China, where an aging population and rising prevalence of respiratory conditions such as COPD and asthma drive market need. The company's integrated approach combines hardware, software, and data analytics to enable continuous health tracking and early intervention. While Qitan Tech has not disclosed funding or valuation details, its established presence and focus on high-growth segments suggest a steady commercial trajectory. The company is well-positioned to capitalize on China's healthcare digitalization push, though competition from larger domestic players and regulatory complexities remain risks. Its private status and limited public information make precise assessment challenging, but the alignment of its product portfolio with national health priorities supports a favorable outlook.

Upcoming Catalysts (preview)

• Q1 2027Launch of next-gen AI-powered wearable for respiratory monitoring70% success
• Q3 2026Partnership with a top-tier hospital network for chronic disease management platform deployment60% success
• Q4 2026NMPA approval for a new AI-based diagnostic device for early COPD detection75% success